Search

A patent application has been submitted for an antigen-binding molecule and combination by inventors from Singapore and Japan. The invention aims to develop a technique that allows antibody drugs to target specific tissues and reduce side effects. The research has potential applications in the development of pharmaceuticals for cancer, immune diseases, chronic diseases, and infections. The patent application provides detailed information on the specific amino acid sequences and modifications of the molecule, which may be of interest to researchers and scientists in the fields of immunology, oncology, and drug development. [Extracted from the article]

South San Francisco, State:California, United States, North and Central America, Antibodies, Biotechnology Companies, Blood Proteins, Business, Drugs and Therapies, Enzymes and Coenzymes, Health and Medicine, Immunoglobulins, Immunology, Protease, Proteins Keywords: South San Francisco; State:California; United States; North and Central America; Antibodies; Biotechnology Companies; Blood Proteins; Business; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Immunoglobulins; Immunology; Protease; Proteins EN South San Francisco State:California United States North and Central America Antibodies Biotechnology Companies Blood Proteins Business Drugs and Therapies Enzymes and Coenzymes Health and Medicine Immunoglobulins Immunology Protease Proteins 2513 2513 1 07/17/23 20230721 NES 230721 2023 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Immunology - Immunoglobulins is the subject of a report. [Extracted from the article]